Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study.

Abstract

INTRODUCTION Epidermal growth factor receptor-tyrosine kinase inhibitors are used as effective first-line and salvage therapy in the treatment of advanced non-small cell lung cancer (NSCLC) patients in East Asia. The objective of this study was to compare the efficacy of gefitinib and erlotinib in Taiwanese patients with advanced NSCLC. METHODS Clinical… (More)
DOI: 10.1097/JTO.0b013e3181f77b27

Topics

Statistics

02040201520162017
Citations per Year

Citation Velocity: 7

Averaging 7 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Fan2011DifferentEO, title={Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study.}, author={Wen-Chien Fan and Chong-Jen Yu and Chun-Ming Tsai and Ming-Shyan Huang and Chun-Liang Lai and Te-chun Hsia and Yin-Jing Tien and Shiang-Fen Huang and Chieh-Hung Wu and Kun-Ta Chou and Yu-chin Lee and Reury-Perng Perng and Yuh-Min Chen}, journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer}, year={2011}, volume={6 1}, pages={148-55} }